CASPOFUNGIN AMNEAL caspofungin (as acetate) 50 mg powder for injection vial

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

caspofungin acetate, Quantity: 55.5 mg (Equivalent: caspofungin, Qty 50 mg)

Disponible desde:

Amneal Pharma Australia Pty Ltd

Designación común internacional (DCI):

caspofungin acetate

formulario farmacéutico:

Injection, powder for

Composición:

Excipient Ingredients: sodium hydroxide; sucrose; hydrochloric acid; mannitol

Vía de administración:

Intravenous Infusion

Unidades en paquete:

1 vial

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

CASPOFUNGIN AMNEAL is indicated for:,? Empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics,? Treatment of:,-Invasive Candidiasis, including candidaemia,-Oesophageal Candidiasis,-Invasive Aspergillosis in patients who are refractory to or intolerant of other therapies.

Resumen del producto:

Visual Identification: Lyophilized white to off-white cake or powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2016-12-22